Quantification of impact of COVID-19 pandemic on cancer screening programmes – a case study from Argentina, Bangladesh, Colombia, Morocco, Sri Lanka, and Thailand
It is quite well documented that the COVID-19 pandemic disrupted cancer screening services in all countries, irrespective of their resources and healthcare settings. While quantitative estimates on reduction in volume of screening tests or diagnostic evaluation are readily available from the high-in...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
eLife Sciences Publications Ltd
2023-05-01
|
| Series: | eLife |
| Subjects: | |
| Online Access: | https://elifesciences.org/articles/86527 |
| _version_ | 1797822395739799552 |
|---|---|
| author | Eric Lucas Raul Murillo Silvina Arrossi Martin Bárcena Youssef Chami Ashrafun Nessa Suraj Perera Padmaka Silva Suleeporn Sangrajrang Richard Muwonge Partha Basu |
| author_facet | Eric Lucas Raul Murillo Silvina Arrossi Martin Bárcena Youssef Chami Ashrafun Nessa Suraj Perera Padmaka Silva Suleeporn Sangrajrang Richard Muwonge Partha Basu |
| author_sort | Eric Lucas |
| collection | DOAJ |
| description | It is quite well documented that the COVID-19 pandemic disrupted cancer screening services in all countries, irrespective of their resources and healthcare settings. While quantitative estimates on reduction in volume of screening tests or diagnostic evaluation are readily available from the high-income countries, very little data are available from the low- and middle-income countries (LMICs). From the CanScreen5 global cancer screening data repository we identified six LMICs through purposive sampling based on the availability of cancer screening data at least for the years 2019 and 2020. These countries represented those in high human development index (HDI) categories (Argentina, Colombia, Sri Lanka, and Thailand) and medium HDI categories (Bangladesh and Morocco). No data were available from low HDI countries to perform similar analysis. The reduction in the volume of tests in 2020 compared to the previous year ranged from 14.1% in Bangladesh to 72.9% in Argentina (regional programme) for cervical screening, from 14.2% in Bangladesh to 49.4% in Morocco for breast cancer screening and 30.7% in Thailand for colorectal cancer screening. Number of colposcopies was reduced in 2020 compared to previous year by 88.9% in Argentina, 38.2% in Colombia, 27.4% in Bangladesh, and 52.2% in Morocco. The reduction in detection rates of CIN 2 or worse lesions ranged from 20.7% in Morocco to 45.4% in Argentina. Reduction of breast cancer detection by 19.1% was reported from Morocco. No association of the impact of pandemic could be seen with HDI categories. Quantifying the impact of service disruptions in screening and diagnostic tests will allow the programmes to strategize how to ramp up services to clear the backlogs in screening and more crucially in further evaluation of screen positives. The data can be used to estimate the impact on stage distribution and avoidable mortality from these common cancers. |
| first_indexed | 2024-03-13T10:08:24Z |
| format | Article |
| id | doaj.art-5921bfc374c5448e916f1be6d0fb1793 |
| institution | Directory Open Access Journal |
| issn | 2050-084X |
| language | English |
| last_indexed | 2024-03-13T10:08:24Z |
| publishDate | 2023-05-01 |
| publisher | eLife Sciences Publications Ltd |
| record_format | Article |
| series | eLife |
| spelling | doaj.art-5921bfc374c5448e916f1be6d0fb17932023-05-22T08:48:09ZengeLife Sciences Publications LtdeLife2050-084X2023-05-011210.7554/eLife.86527Quantification of impact of COVID-19 pandemic on cancer screening programmes – a case study from Argentina, Bangladesh, Colombia, Morocco, Sri Lanka, and ThailandEric Lucas0https://orcid.org/0000-0002-1252-1925Raul Murillo1https://orcid.org/0000-0001-7187-9946Silvina Arrossi2Martin Bárcena3Youssef Chami4Ashrafun Nessa5Suraj Perera6Padmaka Silva7Suleeporn Sangrajrang8Richard Muwonge9Partha Basu10https://orcid.org/0000-0003-0124-4050International Agency for Research on Cancer, Lyon, FranceHospital Universitario San Ignacio, Bogota, ColombiaInvestigadora CEDES/CONICET, Buenos Aires, ArgentinaInstituto Provincial del Cáncer, Jujuy, ArgentinaFoundation Lalla Salma Cancer prevention and treatment, Rabat, MoroccoBangabandhu Sheikh Mujib Medical University, Dhaka, BangladeshMinistry of Health, Colombo, Sri LankaMinistry of Health, Colombo, Sri LankaNational Cancer Institute of Thailand, Bangkok, ThailandInternational Agency for Research on Cancer, Lyon, FranceInternational Agency for Research on Cancer, Lyon, FranceIt is quite well documented that the COVID-19 pandemic disrupted cancer screening services in all countries, irrespective of their resources and healthcare settings. While quantitative estimates on reduction in volume of screening tests or diagnostic evaluation are readily available from the high-income countries, very little data are available from the low- and middle-income countries (LMICs). From the CanScreen5 global cancer screening data repository we identified six LMICs through purposive sampling based on the availability of cancer screening data at least for the years 2019 and 2020. These countries represented those in high human development index (HDI) categories (Argentina, Colombia, Sri Lanka, and Thailand) and medium HDI categories (Bangladesh and Morocco). No data were available from low HDI countries to perform similar analysis. The reduction in the volume of tests in 2020 compared to the previous year ranged from 14.1% in Bangladesh to 72.9% in Argentina (regional programme) for cervical screening, from 14.2% in Bangladesh to 49.4% in Morocco for breast cancer screening and 30.7% in Thailand for colorectal cancer screening. Number of colposcopies was reduced in 2020 compared to previous year by 88.9% in Argentina, 38.2% in Colombia, 27.4% in Bangladesh, and 52.2% in Morocco. The reduction in detection rates of CIN 2 or worse lesions ranged from 20.7% in Morocco to 45.4% in Argentina. Reduction of breast cancer detection by 19.1% was reported from Morocco. No association of the impact of pandemic could be seen with HDI categories. Quantifying the impact of service disruptions in screening and diagnostic tests will allow the programmes to strategize how to ramp up services to clear the backlogs in screening and more crucially in further evaluation of screen positives. The data can be used to estimate the impact on stage distribution and avoidable mortality from these common cancers.https://elifesciences.org/articles/86527COVID-19cancer screeningimpactlow- and middle-income countries |
| spellingShingle | Eric Lucas Raul Murillo Silvina Arrossi Martin Bárcena Youssef Chami Ashrafun Nessa Suraj Perera Padmaka Silva Suleeporn Sangrajrang Richard Muwonge Partha Basu Quantification of impact of COVID-19 pandemic on cancer screening programmes – a case study from Argentina, Bangladesh, Colombia, Morocco, Sri Lanka, and Thailand eLife COVID-19 cancer screening impact low- and middle-income countries |
| title | Quantification of impact of COVID-19 pandemic on cancer screening programmes – a case study from Argentina, Bangladesh, Colombia, Morocco, Sri Lanka, and Thailand |
| title_full | Quantification of impact of COVID-19 pandemic on cancer screening programmes – a case study from Argentina, Bangladesh, Colombia, Morocco, Sri Lanka, and Thailand |
| title_fullStr | Quantification of impact of COVID-19 pandemic on cancer screening programmes – a case study from Argentina, Bangladesh, Colombia, Morocco, Sri Lanka, and Thailand |
| title_full_unstemmed | Quantification of impact of COVID-19 pandemic on cancer screening programmes – a case study from Argentina, Bangladesh, Colombia, Morocco, Sri Lanka, and Thailand |
| title_short | Quantification of impact of COVID-19 pandemic on cancer screening programmes – a case study from Argentina, Bangladesh, Colombia, Morocco, Sri Lanka, and Thailand |
| title_sort | quantification of impact of covid 19 pandemic on cancer screening programmes a case study from argentina bangladesh colombia morocco sri lanka and thailand |
| topic | COVID-19 cancer screening impact low- and middle-income countries |
| url | https://elifesciences.org/articles/86527 |
| work_keys_str_mv | AT ericlucas quantificationofimpactofcovid19pandemiconcancerscreeningprogrammesacasestudyfromargentinabangladeshcolombiamoroccosrilankaandthailand AT raulmurillo quantificationofimpactofcovid19pandemiconcancerscreeningprogrammesacasestudyfromargentinabangladeshcolombiamoroccosrilankaandthailand AT silvinaarrossi quantificationofimpactofcovid19pandemiconcancerscreeningprogrammesacasestudyfromargentinabangladeshcolombiamoroccosrilankaandthailand AT martinbarcena quantificationofimpactofcovid19pandemiconcancerscreeningprogrammesacasestudyfromargentinabangladeshcolombiamoroccosrilankaandthailand AT youssefchami quantificationofimpactofcovid19pandemiconcancerscreeningprogrammesacasestudyfromargentinabangladeshcolombiamoroccosrilankaandthailand AT ashrafunnessa quantificationofimpactofcovid19pandemiconcancerscreeningprogrammesacasestudyfromargentinabangladeshcolombiamoroccosrilankaandthailand AT surajperera quantificationofimpactofcovid19pandemiconcancerscreeningprogrammesacasestudyfromargentinabangladeshcolombiamoroccosrilankaandthailand AT padmakasilva quantificationofimpactofcovid19pandemiconcancerscreeningprogrammesacasestudyfromargentinabangladeshcolombiamoroccosrilankaandthailand AT suleepornsangrajrang quantificationofimpactofcovid19pandemiconcancerscreeningprogrammesacasestudyfromargentinabangladeshcolombiamoroccosrilankaandthailand AT richardmuwonge quantificationofimpactofcovid19pandemiconcancerscreeningprogrammesacasestudyfromargentinabangladeshcolombiamoroccosrilankaandthailand AT parthabasu quantificationofimpactofcovid19pandemiconcancerscreeningprogrammesacasestudyfromargentinabangladeshcolombiamoroccosrilankaandthailand |